Search results

Order by most recent / most popular / relevance

Results: 1-10 of 116

Tuomey violates Stark Law and False Claims Act through physician employment agreements

Barnes & Thornburg LLP
-
USA
-
May 13 2013

After a retrial, a federal jury found South Carolina-based 242-bed Tuomey Healthcare System (Tuomey) guilty last week of violating the Stark Law and

Jury ruled in Tuomey Healthcare retrial that the hospital violated the Stark Law and False Claims Act

King & Spalding LLP
-
USA
-
May 13 2013

On May 8, 2013, a jury concluded that Tuomey Healthcare System, Inc. (Tuomey), a community hospital in Sumter, S.C., violated the Stark Law for

Amphastar’s qui tam suit against Aventis shows importance of patents

Fish & Richardson PC
-
USA
-
May 3 2013

In a recent ground-breaking qui tam ruling, a California federal court denied Aventis Pharma's (a division of Sanofi-Aventis) efforts to dismiss

Law enforcement in the health care industry: what do new cases against Novartis tell us?

Morvillo Abramowitz Grand Iason & Anello PC
-
USA
-
May 9 2013

In recent years, pharmaceutical companies have faced criminal investigations and charges in regard to alleged off-label marketing of prescription

2012 year-end False Claims Act update

Gibson Dunn & Crutcher LLP
-
USA
-
January 8 2013

For years, the Department of Justice ("DOJ") has sought recoveries under the False Claims Act, 31 U.S.C. 3729-33 (the "FCA" or the "Act"), with a torrid

Important court decision for no-fault insurers: federal court rejects limitation on State Farm v. Mallela

Cadwalader Wickersham & Taft LLP
-
USA
-
January 9 2013

Specifically, on January 7, 2013, in the case of Allstate Ins. Co. v. Elzanaty, the United States District Court for the Eastern District of New York

Advice of counsel defense in US v. Lauren Stevens: dismissal of indictment is not necessarily good news for companies

Hogan Lovells
-
USA
-
March 25 2011

The indictment last November of former GlaxoSmithKline (GSK) in-house counsel, Lauren Stevens, for purportedly obstructing a U.S. Food and Drug Administration (FDA) investigation into whether GSK marketed Wellbutrin, an anti-depressant drug, off-label, falsifying and concealing documents, and making false statements sent shockwaves through the legal community

Health care enforcement: 2012 trends: quarterly review Part IV in a continuing series on health care enforcement

Mintz Levin Cohn Ferris Glovsky and Popeo PC
-
USA
-
May 8 2012

Mintz Levin’s Health Care Fraud Enforcement Defense group has published a series of “Year in Review” articles discussing its observations about health care fraud enforcement trends in 2011 and its opinions as to what these trends might mean for 2012

$762 million settlement by Amgen of civil, criminal, and kickback claims approved by judge

Squire Sanders
-
USA
-
December 20 2012

Yesterday, Amgen received approval of a global settlement from the federal judge in New York presiding over the criminal case filed against Amgen by the Department of Justice regarding the off-label promotion of the anemia drug Aranesp

House of Lords confirms that price fixing can be criminal conspiracy to defraud strengthening NHS bargaining position and creating calls for OFT clarification

Shepherd & Wedderburn LLP
-
United Kingdom
-
March 12 2008

Two eagerly awaited House of Lords decisions were delivered today and have provided very useful clarity that price fixing can be prosecuted as common law conspiracy to defraud (in addition to prosecution under the Enterprise Act 2002) if aggravating factors, such as misrepresentation, are present

next >

Search results

Tuomey violates Stark Law and False Claims Act through physician employment agreements

Jury ruled in Tuomey Healthcare retrial that the hospital violated the Stark Law and False Claims Act

Amphastar’s qui tam suit against Aventis shows importance of patents

Law enforcement in the health care industry: what do new cases against Novartis tell us?

2012 year-end False Claims Act update

Important court decision for no-fault insurers: federal court rejects limitation on State Farm v. Mallela

Advice of counsel defense in US v. Lauren Stevens: dismissal of indictment is not necessarily good news for companies

Health care enforcement: 2012 trends: quarterly review Part IV in a continuing series on health care enforcement

$762 million settlement by Amgen of civil, criminal, and kickback claims approved by judge

House of Lords confirms that price fixing can be criminal conspiracy to defraud strengthening NHS bargaining position and creating calls for OFT clarification

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea